Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men

Heart

Volumn 95, Issue 13, 2009, Pages 1067-1071

  Kurl, S ^a   Ala Kopsala, M ^b   Ruskoaho, H ^b   Makikallio T ^b,c   Nyyssonen K ^a   Vuolteenaho, O ^b   Sivenius, J ^d   Salonen, J T ^a   Laukkanen, J A ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c LAPLAND CENTRAL HOSPITAL   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FINLAND; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STROKE;

AGED; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; RISK ASSESSMENT; STROKE;

EID: 67649607629     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.150342     Document Type: Article

References (39)

1. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New Engl J Med 2002;347:161-167 (Pubitemid 34764819)
2. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-1729
3. Yamamoto K, Burnett JC Jr, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-994 (Pubitemid 26415815)
4. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. New Engl J Med 1998;339:321-328 (Pubitemid 28366422)
5. Richards AM, McDonald D, Fitzpatrick MA, et al. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab 1988;67:1134-1139 (Pubitemid 19012942)
6. DeLemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-322 (Pubitemid 36936846)
7. Jernberg T, Stridsberg M, Venge P, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Card 2002;40:437-445 (Pubitemid 34833157)
8. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003;41:1264-1272 (Pubitemid 36438985)
9. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002;44:293-321. (Pubitemid 34438288)
10. Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003;107:1278-1283 (Pubitemid 36314411)
11. McDonagh TA, Cunningham AD, Morrison CE, et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001;86:21-26 (Pubitemid 32977774)
12. Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997;77:264-267 (Pubitemid 27122781)
13. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. New Engl J Med 2004;350:655-663 (Pubitemid 38364624)
14. Laukkanen JA, Kurl S, Ala-Kopsala M, et al. Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men. Eur Heart J 2006;10:1230-1237 (Pubitemid 43752394)
15. Nogami M, Shiga J, Takatsu A, et al. Immunohistochemistry of atrial natriuretic peptide in brain infarction. Histochem J 2001;33:87-90. (Pubitemid 32521454)
16. Giuffrida R, Bellomo M, Polizzi G, et al. Ischemia-induced changes in the immunoreactivity for endothelin and other vasoactive peptides in the brain of the mongolian gerbil. J Cardiovasc Pharmacol 1992;20:S41-4. (Pubitemid 23014104)
17. Mäkikallio AM, Mäkikallio TH, Korpelainen JT, et al. Natriuretic peptides and mortality after stroke. Stroke 2005;36:1016-1020 (Pubitemid 40629295)
18. Ala-Kopsala M, Magga J, Peuhkurinen K, et al. Molecular heterogenity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 2004;50:1576-1588 (Pubitemid 39121226)
19. Everson SA, Kaplan GA, Goldberg DE, et al. Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged men. Hypertension 1996;27:1059-1064 (Pubitemid 26140661)
20. Salonen JT, Salonen R, Seppanen K, et al. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 1991;84:129-139
21. Lakka TA, Venalainen JM, Rauramaa R, et al. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. New Engl J Med 1994;330:1549-1554 (Pubitemid 24160957)
22. Kurl S, Laukkanen JA, Niskanen L, et al. Cardiac power during exercise and the risk of stroke in men. Stroke 2005;36:820-824 (Pubitemid 40500470)
23. Kurl S, Laukkanen JA, Rauramaa R, et al. Systolic blood pressure response to exercise stress test and risk of stroke. Stroke 2001;32:2036-2041 (Pubitemid 32868094)
24. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106:416-422 (Pubitemid 34803684)
25. Estrada V, Tellez MJ, Moya J, et al. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens 1994;7:1085-1089
26. Eguchi K, Kario K, Shimada K, et al. Circadian variation of blood pressure and neurohumoral factors during the acute phase of stroke. Clin Exp Hypertens 2002;24:109-114 (Pubitemid 34132368)
27. Rubattu S, Stanzione R, Angelantonio E, et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004;35:814-818 (Pubitemid 38419783)
28. Sviri GE, Shik V, Raz B, et al. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir 2003;145:851-860 (Pubitemid 37352430)
29. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003;108:275-281 (Pubitemid 36899016)
30. Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287-296
31. Yamada T, Fukunami M, Shimonagata T, et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. J Am Coll Cardiol 2000;35:405-413 (Pubitemid 30125532)
32. Hakala T, Hedman A, Turpeinen A, et al. Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions. Eur J Cardiothorac Surg 2002;22:939-943 (Pubitemid 35430221)
33. Schirmer H, Omland T. Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population. The Tromso Study. Eur Heart J 1999;20:755-763 (Pubitemid 29209909)
34. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601. (Pubitemid 34123434)
35. Ellinor PT, Low AF, Patton KK, et al. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005;45:82-86 (Pubitemid 40052031)
36. Dessi-Fulgheri P, Palermo R, Di Noto G, et al. High levels of plasma atrial natriuretic factor and impaired left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Hypertens 1992;10:161-165
37. Tuinenburg AE, Brundel BJ, Van Gelder IC, et al. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:827-835 (Pubitemid 29247345)
38. Heeschen C, Hamm CW, Mitrovic V, et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-3212 (Pubitemid 39525067)
39. Schnabel R, Rupprecht HJ, Lackner KJ, et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2005;26:241-249 (Pubitemid 40222362)